ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
Condition(s):Biliary Tract Neoplasms; Cholangiocarcinoma; Gallbladder NeoplasmsLast Updated:May 13, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Biliary Tract Neoplasms; Cholangiocarcinoma; Gallbladder NeoplasmsLast Updated:May 13, 2016Completed
Condition(s):DepressionLast Updated:April 13, 2023Active, not recruiting
Condition(s):Hepatocellular Carcinoma (HCC); Cholangiocarcinoma; Esophageal Cancer; Nasopharyngeal Cancer; Ovarian Cancer; Solid TumorsLast Updated:July 15, 2020Terminated
Condition(s):Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver CancerLast Updated:August 4, 2023Terminated
Condition(s):Biliary Cancer; Bile Duct Cancer; Cancer of the Bile DuctLast Updated:March 28, 2024Not yet recruiting
Condition(s):Carcinoma of Intrahepatic and Extra-hepatic Biliary System; Carcinoma of Gallbladder; Bile Duct Cancer; CholangiocarcinomaLast Updated:September 10, 2018Completed
Condition(s):Pancreatic Cancer; Bile Duct Cancer; Ampulla of Vater CancerLast Updated:April 20, 2023Active, not recruiting
Condition(s):Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver CancerLast Updated:June 11, 2010Terminated
Condition(s):Gastrointestinal Neoplasms; Cholangiocarcinoma; Pancreatic NeoplasmsLast Updated:January 12, 2024Completed
Condition(s):Cholangiocarcinoma; Gall Bladder Carcinoma; Cholangiocarcinoma Non-resectable; Gallbladder Carcinoma Non-ResectableLast Updated:June 15, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.